{
    "url_original": "https://www.wsj.com/articles/fda-review-of-pfizer-covid-19-vaccine-for-kids-expected-11634900401?mod=business_lead_pos2",
    "url": "fda-review-of-pfizer-covid-19-vaccine-for-kids-expected-11634900401",
    "title": "Pfizer-BioNTech Covid-19 Vaccine for Kids Was Safe and 90.7% Effective, Companies Say",
    "sub_head": "The FDA is expected to soon release its own evaluation of testing data on the shotâ€™s safety and effectiveness in 5- to 11-year-olds, a step toward authorization of use",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2021-10-22 08:52:00",
    "body": "U.S. health regulators are expected to weigh in soon on the evidence for giving the Covid-19 vaccine from  Pfizer Inc.  and  BioNTech SE  to children 5 to 11 years old.<br />The companies released new data Friday showing the vaccine was 90.7% effective at preventing symptomatic Covid-19 in a study of children in this age group, information that health authorities will likely factor as they weigh whether to authorize the shots for use."
}